iTonic Holdings Ltd. (ITOC) Stock Analysis & Investment Frameworks

iTonic Holdings Ltd. (ITOC) stock analysis on Invetso. Review iTonic Holdings Ltd.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

iTonic Holdings Ltd. Company Overview

iTonic Holdings Ltd. Key Financial Metrics

About iTonic Holdings Ltd.

iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients. Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.

iTonic Holdings Ltd. Investment Frameworks

Invetso analyzes iTonic Holdings Ltd. (ITOC) across the following frameworks:

Explore More ITOC Research